The role of FKBP5 in cancer aetiology and chemoresistance

L. Li, Z. Lou, L. Wang

Research output: Contribution to journalReview articlepeer-review

64 Scopus citations


FK506 binding protein 51 (FKBP51, also called FKBP5) belongs to a family of immunophilins, FK506 binding proteins (FKBPs). Members of this family are targets for drugs such as rapamycin and cyclosporine. Although FKBP5 shares characteristics with other FKBPs, it also has unique features, especially its role in the regulation of multiple signalling pathways and in tumourigenesis and chemoresistance. In this review, we will focus on the recently discovered role of FKBP5 in cancer aetiology and response to antineoplastic therapy.

Original languageEnglish (US)
Pages (from-to)19-23
Number of pages5
JournalBritish journal of cancer
Issue number1
StatePublished - Jan 4 2011


  • FKBP5
  • chemoresistance
  • immunophilins

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'The role of FKBP5 in cancer aetiology and chemoresistance'. Together they form a unique fingerprint.

Cite this